
|Articles|June 20, 2019
Proscia Launches AI-Powered Digital Pathology Solution
Advertisement
Proscia has released DermAI, a module on Proscia’s Concentriq Platform that leverages deep learning to pre-screen and classify skin biopsies. Proscia intends to submit DermAI to the FDA for review to use in clinical diagnosis.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Imfinzi Plus FLOT for Early and Locally Advanced Gastric and GEJ Cancers
2
Is Artificial Intelligence Coming for Clinical Research?
3
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
4
The CRA Role’s Co-evolution With Clinical Trial Technology
5






.png)



.png)



.png)
.png)
